ARTOFA ER 11 TABLET

Product Description

ARTOFA ER 11 TABLET
Extended-Release Relief for Autoimmune Disorders Tofacitinib 11mg Tablet

Product Description:
ARTOFA ER 11 TABLET contains Tofacitinib Extended Release 11mg, a once-daily JAK inhibitor designed for sustained relief from autoimmune conditions such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. The extended-release formulation offers consistent therapeutic action, enhancing patient compliance and clinical outcomes.

Manufactured by Agrosaf Pharmaceuticals Pvt. Ltd., ARTOFA ER 11 delivers high-quality, long-acting immunomodulatory therapy trusted by healthcare professionals across chronic care segments.

Key Benefits:

• Once-daily extended-release formulation for steady symptom control

• Reduces joint inflammation, stiffness, and pain

• Enhances mobility and quality of life in autoimmune patients

• Ideal for long-term disease management with improved adherence

• Supported by global guidelines for moderate to severe autoimmune conditions

Therapeutic Indications:

• Rheumatoid Arthritis

• Psoriatic Arthritis

• Ulcerative Colitis (in patients unresponsive to conventional therapies)

Target Buyers:
Recommended for hospital pharmacies, rheumatology suppliers, immunology wholesalers, chronic care distributors, and bulk pharmaceutical buyers serving autoimmune treatment markets.

Packaging:

Available in secure blister or HDPE packs, with bulk packaging options for hospitals, clinics, and B2B procurement.

ARTOFA ER 11 TABLET Sustained autoimmune relief, powered by extended-release Tofacitinib. From Agrosaf Pharmaceuticals.